Breaking News

Rentschler Secures Client for New U.S. Mfg. Facility

Massachusetts facility will focus on commercial production of highly complex molecules for international clients.

Rentschler Biopharma SE, a global contract development and manufacturing organization (CDMO) for biopharmaceuticals, has secured a major client for its new Rentschler Biopharma Manufacturing Center (RBMC) facility at its site in Milford, MA. The RBMC is expected to be operational in the second half of 2024. The company, a long-standing client of Rentschler Biopharma in Germany, has contracted to have its lead product manufactured at the RBMC for clinical supply. The protein therapeutic is see...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters